fda glp-1 warning october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA is moving to restrict
Description
Customer reviews are not provided for consumer reference
"Fortunately, these medications, to date, have proven to be comparatively low risk," said Dr
11041106, Oct
MHT is a member of the scientific advisory board of ERX Pharmaceuticals, Cambridge, Mass
Others, however, dont respond or develop problematic side effects that interfere with eating patterns in different ways, she says
